Seizert Capital Partners, LLC Ani Pharmaceuticals Inc Transaction History

Seizert Capital Partners, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$58.53 - $68.82 $35,410 - $41,636	-605 Reduced 12.09%	4,400 $280,000
Q4 2023 Feb 07, 2024	SELL	$48.72 - $65.43 $67,964 - $91,274	-1,395 Reduced 21.8%	5,005 $275,000
Q3 2023 Nov 06, 2023	BUY	$50.28 - $64.61 $100,710 - $129,413	2,003 Added 45.55%	6,400 $371,000
Q2 2023 Jul 27, 2023	BUY	$37.29 - $53.83 $163,964 - $236,690	4,397 New	4,397 $236,000
Q3 2020 Nov 03, 2020	SELL	$26.38 - $33.1 $788,814 - $989,756	-29,902 Closed	0 $0
Q2 2020 Aug 06, 2020	SELL	$29.93 - $50.1 $148,722 - $248,946	-4,969 Reduced 14.25%	29,902 $967,000
Q1 2020 May 05, 2020	SELL	$30.35 - $67.14 $92,871 - $205,448	-3,060 Reduced 8.07%	34,871 $1.42 Million
Q4 2019 Feb 10, 2020	SELL	$55.65 - $79.83 $61,994 - $88,930	-1,114 Reduced 2.85%	37,931 $2.34 Million
Q3 2019 Nov 07, 2019	BUY	$64.7 - $85.39 $624,225 - $823,842	9,648 Added 32.82%	39,045 $2.85 Million
Q2 2019 Aug 06, 2019	BUY	$67.77 - $82.2 $1.99 Million - $2.42 Million	29,397 New	29,397 $2.42 Million

212

18.8M

11.7K

10.5K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $982M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Seizert Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Seizert Capital Partners, LLC with notifications on news.